Actively Recruiting

Phase Not Applicable
Age: 15Years - 29Years
All Genders
ID05958316

A Randomized Controlled Trial Using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

Led by Virginia Commonwealth University · Updated on 2026-05-22

126

Participants Needed

5

Research Sites

N/A

Total Duration

On this page

Sponsors

V

Virginia Commonwealth University

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of the Computerized Symptom Assessment Tool (C-SCAT) compared to usual care on improving self-efficacy for managing symptoms and symptom self-management behaviors in adolescents and young adults with cancer. This randomized controlled trial involves participants who are within the first three months of a cancer diagnosis and receiving cancer treatment defined as prescribed infusions like chemotherapy or immunotherapy. Participants will be randomly assigned to one of two groups. One group will use the C-SCAT tool during three clinic visits over about 12 weeks, where they assess and describe their symptoms in detail before meeting with their healthcare providers. The other group will receive usual symptom care during their scheduled visits for up to 12 weeks, with study staff maintaining contact to encourage ongoing participation. During the study, participants will complete symptom assessments and questionnaires at baseline, immediately after the intervention, and at follow-up to measure self-efficacy for symptom management and symptom self-management behaviors. Researchers will also evaluate symptom severity, distress, and social function using various scales. The total participation period includes the intervention and follow-up assessments, with outcomes measured at specific timepoints to understand the impact of the C-SCAT tool.

CONDITIONS

Brief Title

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

Who Can Participate

Age: 15Years - 29Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Has received at least 1 cycle of cancer treatment and is within 3 months of receiving that first cycle of treatment
  • Receiving regularly scheduled cancer treatment and will be receiving at least three more cycles
  • Reports at least 1 symptom related to cancer and/or its treatment
  • Able to speak, read, and write English as required for completion of the C-SCAT and study measures
Not Eligible

You will not qualify if you...

  • Cognitive and/or physical inability to complete study measures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to about 12 weeks, depending on cancer treatment schedule

Participants receive cancer treatment with infusion (e.g., chemotherapy, immunotherapy). Those in the intervention group complete the Computerized Symptom Assessment Tool (C-SCAT) prior to three clinic visits to improve symptom self-management. Those in the control group receive usual care with three contacts from study staff during the intervention period.

3 clinic visits for cancer treatment

Follow-up

Duration - 4 weeks following treatment

Participants are assessed for symptom self-management and social function outcomes up to 4 weeks after the treatment period ends.

1 follow-up visit

Trial Site Locations

Total: 5 locations

1

Children's Mercy Hospital

Kansas City, Missouri, United States, 64108

Actively Recruiting

2

University of Utah Huntsman Cancer Institute (HCI)

Salt Lake City, Utah, United States, 84112

Actively Recruiting

3

University of Utah Primary Children's Hospital

Salt Lake City, Utah, United States, 84113

Actively Recruiting

4

Virginia Commonwealth University

Richmond, Virginia, United States, 23298

Actively Recruiting

5

Seattle Children's Hospital @ University of Washington

Seattle, Washington, United States, 98105

Active, Not Recruiting

Loading map...

Research Team

G

Grace Hodges

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here